Human Chorionic Gonadotropin (HCG) Industry - Regional Synopsis
APAC Market Statistics
Geographically, the human chorionic gonadotropin (HCG) market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. Asia Pacific industry is poised to hold largest revenue share by 2037, owing to growing population, increasing concern and awareness among the individuals in the region.
North America Market Analysis
Furthermore, in 2021, the human chorionic gonadotropin (HCG) market in North America is evaluated to occupy the largest share in terms of revenue, owing to the increasing incidence of infertility among the women aged between 15-44 years in the region. According to the report published by the Centers for Disease Control and Prevention (CDC), annually approximately 10% of the women which accounts for 6.1 million in the United States face difficulty to conceive or staying pregnant. Such increasing issues during the reproductive age among the individuals and couples is further expected to drive the demand for Human chorionic gonadotropin (HCG) in the North American countries. Alternatively, the market in Europe is also anticipated to occupy a significant share in the global Human chorionic gonadotropin (HCG) market on account of its proven success in terms of technology development in the region.
